These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 3669742

  • 1. Cytotoxicity and differentiating actions of adriamycin in WEHI-3B D+ leukemia cells.
    Gamba-Vitalo C, Blair OC, Tritton TR, Lane PA, Carbone R, Sartorelli AC.
    Leukemia; 1987 Mar; 1(3):188-97. PubMed ID: 3669742
    [Abstract] [Full Text] [Related]

  • 2. Induction of the differentiation of WEHI-3B D+ monomyelocytic leukemia cells by inhibitors of topoisomerase II.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1990 Oct 15; 50(20):6723-30. PubMed ID: 2170008
    [Abstract] [Full Text] [Related]

  • 3. Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
    Gamba-Vitalo C, Blair OC, Keyes SR, Sartorelli AC.
    Cancer Res; 1986 Mar 15; 46(3):1189-94. PubMed ID: 3455881
    [Abstract] [Full Text] [Related]

  • 4. [Cell differentiation action of 4'-epi-adriamycin in WEHI-3B myelomonocytic leukemia cells].
    Kajigaya Y, Ikuta K, Sasaki H, Matsuyama S.
    Gan To Kagaku Ryoho; 1991 Nov 15; 18(14):2409-15. PubMed ID: 1952960
    [Abstract] [Full Text] [Related]

  • 5. Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1992 May 15; 52(10):2782-90. PubMed ID: 1316227
    [Abstract] [Full Text] [Related]

  • 6. Role of vitamin D3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid.
    Li J, Finch RA, Sartorelli AC.
    Exp Cell Res; 1999 Jun 15; 249(2):279-90. PubMed ID: 10366427
    [Abstract] [Full Text] [Related]

  • 7. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F, Israel M, Silber R, Seshadri R, Kirschenbaum S, Potmesil M.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [Abstract] [Full Text] [Related]

  • 8. The role of DNA ploidy in the differentiation of WEHI-3B D- leukemia cells transfected with the granulocyte colony-stimulating factor receptor gene.
    Li J, Koay DC, Sartorelli AC.
    Exp Cell Res; 1995 Aug 15; 219(2):579-88. PubMed ID: 7543855
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of a repressor of the differentiation of WEHI-3B D- leukemia cells.
    Li J, Finch RA, Xiao W, Sartorelli AC.
    Exp Cell Res; 1998 Jul 10; 242(1):274-84. PubMed ID: 9665825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of the cell cycle-dependent cytotoxicity of adriamycin and 4-hydroperoxycyclophosphamide by novobiocin, an inhibitor of mammalian topoisomerase II.
    Lee FY, Flannery DJ, Siemann DW.
    Cancer Res; 1992 Jul 01; 52(13):3515-20. PubMed ID: 1319822
    [Abstract] [Full Text] [Related]

  • 13. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Burres NS, Myers MT, Sartorelli AC.
    Cancer Biochem Biophys; 1988 Jul 01; 10(1):47-57. PubMed ID: 3224331
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
    Ling YH, el-Naggar AK, Priebe W, Perez-Soler R.
    Mol Pharmacol; 1996 May 01; 49(5):832-41. PubMed ID: 8622633
    [Abstract] [Full Text] [Related]

  • 17. Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine.
    Teodori L, Barlogie B, Drewinko B, Swartzendruber D, Mauro F.
    Cancer Res; 1981 Apr 01; 41(4):1263-70. PubMed ID: 7214318
    [Abstract] [Full Text] [Related]

  • 18. Flow-cytometric analysis of in vivo induction of differentiation of WEHI-3B myelomonocytic leukemia cells by recombinant granulocyte colony-stimulating factor.
    Hayashi M, Okabe-Kado J, Hozumi M.
    Exp Hematol; 1994 Apr 01; 22(4):393-8. PubMed ID: 7512048
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL, Blair OC, Sartorelli AC.
    Cancer Res; 1984 Sep 01; 44(9):3907-10. PubMed ID: 6589046
    [Abstract] [Full Text] [Related]

  • 20. Myeloid differentiation associated tyrosine protein kinase activity in WEHI-3B murine monomyelocytic leukemia cells.
    DiGiovanna MP, Sartorelli AC.
    Leukemia; 1991 Oct 01; 5(10):869-78. PubMed ID: 1720491
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.